Compound library / Fat Loss / GLP-1
Dual GLP-1/glucagon receptor agonist developed in China (Innovent/Eli Lilly), approved in China for weight management and in trials elsewhere.
| Category | Fat Loss / GLP-1 |
|---|---|
| Typical route | Subcutaneous |
| Half-life | ~6 days |
| Common dose range | Trial/regional dosing varies; not approved in the US |
| Typical cycle length | Ongoing where regionally approved |
BioHack Track models Mazdutide at a half-life of 144 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Not commercially available in the US outside clinical trials.
Refrigerate where commercially supplied (e.g. China).
Not FDA-approved; US access is grey-market only with unverifiable sourcing/purity.
Track Mazdutide in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Mazdutide — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.